ID C4BPB_HUMAN Reviewed; 252 AA. AC P20851; A5JYP8; D3DT81; Q5VVR0; Q9BS25; DT 01-FEB-1991, integrated into UniProtKB/Swiss-Prot. DT 01-FEB-1991, sequence version 1. DT 27-MAR-2024, entry version 191. DE RecName: Full=C4b-binding protein beta chain; DE Flags: Precursor; GN Name=C4BPB; OS Homo sapiens (Human). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae; OC Homo. OX NCBI_TaxID=9606; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1). RX PubMed=8325877; DOI=10.1016/s0021-9258(18)82432-2; RA Hillarp A., Pardo-Manuel F., Ruiz R., de Cordoba S., Dahlback B.; RT "The human C4b-binding protein beta-chain gene."; RL J. Biol. Chem. 268:15017-15023(1993). RN [2] RP NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1). RX PubMed=2300577; DOI=10.1073/pnas.87.3.1183; RA Hillarp A., Dahlback B.; RT "Cloning of cDNA coding for the beta chain of human complement component RT C4b-binding protein: sequence homology with the alpha chain."; RL Proc. Natl. Acad. Sci. U.S.A. 87:1183-1187(1990). RN [3] RP NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANT GLN-102. RG SeattleSNPs variation discovery resource; RL Submitted (MAY-2007) to the EMBL/GenBank/DDBJ databases. RN [4] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RX PubMed=16710414; DOI=10.1038/nature04727; RA Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D., Dunham A., RA Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A., Jones M.C., Gillson C., RA Searle S., Zhou Y., Kokocinski F., McDonald L., Evans R., Phillips K., RA Atkinson A., Cooper R., Jones C., Hall R.E., Andrews T.D., Lloyd C., RA Ainscough R., Almeida J.P., Ambrose K.D., Anderson F., Andrew R.W., RA Ashwell R.I.S., Aubin K., Babbage A.K., Bagguley C.L., Bailey J., RA Beasley H., Bethel G., Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., RA Buckley D., Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., RA Clarke G., Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., RA Davies J., Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H., RA Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L., RA Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J., RA Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R., Hammond S., RA Harrison E.S.I., Hart E., Haugen E., Heath P.D., Holmes S., Holt K., RA Howden P.J., Hunt A.R., Hunt S.E., Hunter G., Isherwood J., James R., RA Johnson C., Johnson D., Joy A., Kay M., Kershaw J.K., Kibukawa M., RA Kimberley A.M., King A., Knights A.J., Lad H., Laird G., Lawlor S., RA Leongamornlert D.A., Lloyd D.M., Loveland J., Lovell J., Lush M.J., RA Lyne R., Martin S., Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., RA McLaren S., Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N., RA Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V., RA Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J., RA Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E., RA Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C., Subramanian S., RA Sycamore N., Tracey A., Tromans A., Van Helmond Z., Wall M., Wallis J.M., RA White S., Whitehead S.L., Wilkinson J.E., Willey D.L., Williams H., RA Wilming L., Wray P.W., Wu Z., Coulson A., Vaudin M., Sulston J.E., RA Durbin R.M., Hubbard T., Wooster R., Dunham I., Carter N.P., McVean G., RA Ross M.T., Harrow J., Olson M.V., Beck S., Rogers J., Bentley D.R.; RT "The DNA sequence and biological annotation of human chromosome 1."; RL Nature 441:315-321(2006). RN [5] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RA Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M., RA Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J., RA Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S., RA Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H., RA Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K., RA Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D., RA Hunkapiller M.W., Myers E.W., Venter J.C.; RL Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases. RN [6] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2). RC TISSUE=Skeletal muscle; RX PubMed=15489334; DOI=10.1101/gr.2596504; RG The MGC Project Team; RT "The status, quality, and expansion of the NIH full-length cDNA project: RT the Mammalian Gene Collection (MGC)."; RL Genome Res. 14:2121-2127(2004). RN [7] RP GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-64; ASN-71 AND ASN-98. RC TISSUE=Plasma; RX PubMed=14760718; DOI=10.1002/pmic.200300556; RA Bunkenborg J., Pilch B.J., Podtelejnikov A.V., Wisniewski J.R.; RT "Screening for N-glycosylated proteins by liquid chromatography mass RT spectrometry."; RL Proteomics 4:454-465(2004). RN [8] RP GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-64 AND ASN-98. RC TISSUE=Plasma; RX PubMed=16335952; DOI=10.1021/pr0502065; RA Liu T., Qian W.-J., Gritsenko M.A., Camp D.G. II, Monroe M.E., Moore R.J., RA Smith R.D.; RT "Human plasma N-glycoproteome analysis by immunoaffinity subtraction, RT hydrazide chemistry, and mass spectrometry."; RL J. Proteome Res. 4:2070-2080(2005). RN [9] RP GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-98. RC TISSUE=Liver; RX PubMed=19159218; DOI=10.1021/pr8008012; RA Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.; RT "Glycoproteomics analysis of human liver tissue by combination of multiple RT enzyme digestion and hydrazide chemistry."; RL J. Proteome Res. 8:651-661(2009). CC -!- FUNCTION: Controls the classical pathway of complement activation. It CC binds as a cofactor to C3b/C4b inactivator (C3bINA), which then CC hydrolyzes the complement fragment C4b. It also accelerates the CC degradation of the C4bC2a complex (C3 convertase) by dissociating the CC complement fragment C2a. It also interacts with anticoagulant protein S CC and with serum amyloid P component. The beta chain binds protein S. CC -!- SUBUNIT: Disulfide-linked complex of alpha and beta chains of 3 CC possible sorts: a 570 kDa complex of 7 alpha chains and 1 beta chain, a CC 530 kDa homoheptamer of alpha chains or a 500 kDa complex of 6 alpha CC chains and 1 beta chain. The central body of the alpha chain homomer CC supports tentacles, each with the binding site for C4b at the end. CC -!- SUBCELLULAR LOCATION: Secreted. CC -!- ALTERNATIVE PRODUCTS: CC Event=Alternative splicing; Named isoforms=2; CC Name=1; CC IsoId=P20851-1; Sequence=Displayed; CC Name=2; CC IsoId=P20851-2; Sequence=VSP_022594; CC -!- WEB RESOURCE: Name=SeattleSNPs; CC URL="http://pga.gs.washington.edu/data/c4bpb/"; CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; L11244; AAA35615.1; -; mRNA. DR EMBL; L11245; AAA35616.1; -; mRNA. DR EMBL; M29964; AAB59520.1; -; mRNA. DR EMBL; EF613556; ABQ52216.1; -; Genomic_DNA. DR EMBL; AL445493; -; NOT_ANNOTATED_CDS; Genomic_DNA. DR EMBL; CH471100; EAW93504.1; -; Genomic_DNA. DR EMBL; CH471100; EAW93506.1; -; Genomic_DNA. DR EMBL; BC005378; AAH05378.1; -; mRNA. DR CCDS; CCDS1476.1; -. [P20851-1] DR CCDS; CCDS31005.1; -. [P20851-2] DR PIR; A47107; A34877. DR RefSeq; NP_000707.1; NM_000716.3. [P20851-1] DR RefSeq; NP_001017364.1; NM_001017364.1. [P20851-2] DR RefSeq; NP_001017365.1; NM_001017365.2. [P20851-1] DR RefSeq; NP_001017366.1; NM_001017366.2. [P20851-2] DR RefSeq; NP_001017367.1; NM_001017367.1. [P20851-1] DR RefSeq; XP_005273311.1; XM_005273254.4. [P20851-1] DR AlphaFoldDB; P20851; -. DR SMR; P20851; -. DR BioGRID; 107186; 36. DR IntAct; P20851; 13. DR STRING; 9606.ENSP00000243611; -. DR DrugBank; DB01593; Zinc. DR DrugBank; DB14487; Zinc acetate. DR DrugBank; DB14533; Zinc chloride. DR DrugBank; DB14548; Zinc sulfate, unspecified form. DR GlyConnect; 1052; 8 N-Linked glycans (5 sites). DR GlyCosmos; P20851; 7 sites, 11 glycans. DR GlyGen; P20851; 7 sites, 13 N-linked glycans (5 sites), 1 O-linked glycan (1 site). DR iPTMnet; P20851; -. DR PhosphoSitePlus; P20851; -. DR BioMuta; C4BPB; -. DR DMDM; 115213; -. DR jPOST; P20851; -. DR MassIVE; P20851; -. DR MaxQB; P20851; -. DR PaxDb; 9606-ENSP00000243611; -. DR PeptideAtlas; P20851; -. DR ProteomicsDB; 53819; -. [P20851-1] DR ProteomicsDB; 53820; -. [P20851-2] DR Antibodypedia; 20697; 317 antibodies from 27 providers. DR DNASU; 725; -. DR Ensembl; ENST00000243611.9; ENSP00000243611.5; ENSG00000123843.13. [P20851-1] DR Ensembl; ENST00000367076.7; ENSP00000356043.3; ENSG00000123843.13. [P20851-2] DR Ensembl; ENST00000367078.8; ENSP00000356045.3; ENSG00000123843.13. [P20851-1] DR Ensembl; ENST00000391923.1; ENSP00000375790.1; ENSG00000123843.13. [P20851-1] DR GeneID; 725; -. DR KEGG; hsa:725; -. DR MANE-Select; ENST00000367078.8; ENSP00000356045.3; NM_001017365.3; NP_001017365.1. DR UCSC; uc001hfj.4; human. [P20851-1] DR AGR; HGNC:1328; -. DR CTD; 725; -. DR DisGeNET; 725; -. DR GeneCards; C4BPB; -. DR HGNC; HGNC:1328; C4BPB. DR HPA; ENSG00000123843; Tissue enriched (liver). DR MIM; 120831; gene. DR neXtProt; NX_P20851; -. DR OpenTargets; ENSG00000123843; -. DR PharmGKB; PA25908; -. DR VEuPathDB; HostDB:ENSG00000123843; -. DR eggNOG; KOG4297; Eukaryota. DR GeneTree; ENSGT00940000163065; -. DR HOGENOM; CLU_093877_0_0_1; -. DR InParanoid; P20851; -. DR OMA; ICIKGYH; -. DR OrthoDB; 4519459at2759; -. DR PhylomeDB; P20851; -. DR TreeFam; TF342864; -. DR PathwayCommons; P20851; -. DR Reactome; R-HSA-977606; Regulation of Complement cascade. DR SignaLink; P20851; -. DR BioGRID-ORCS; 725; 10 hits in 1147 CRISPR screens. DR GenomeRNAi; 725; -. DR Pharos; P20851; Tbio. DR PRO; PR:P20851; -. DR Proteomes; UP000005640; Chromosome 1. DR RNAct; P20851; Protein. DR Bgee; ENSG00000123843; Expressed in right lobe of liver and 115 other cell types or tissues. DR ExpressionAtlas; P20851; baseline and differential. DR GO; GO:0005576; C:extracellular region; NAS:UniProtKB. DR GO; GO:0005615; C:extracellular space; IDA:BHF-UCL. DR GO; GO:0005886; C:plasma membrane; TAS:Reactome. DR GO; GO:0007596; P:blood coagulation; TAS:ProtInc. DR GO; GO:0006958; P:complement activation, classical pathway; IEA:UniProtKB-KW. DR GO; GO:0045087; P:innate immune response; IEA:UniProtKB-KW. DR GO; GO:0045959; P:negative regulation of complement activation, classical pathway; IDA:BHF-UCL. DR GO; GO:0045732; P:positive regulation of protein catabolic process; IDA:BHF-UCL. DR GO; GO:1903027; P:regulation of opsonization; IDA:BHF-UCL. DR GO; GO:0009609; P:response to symbiotic bacterium; IDA:BHF-UCL. DR CDD; cd00033; CCP; 3. DR Gene3D; 2.10.70.10; Complement Module, domain 1; 3. DR InterPro; IPR035976; Sushi/SCR/CCP_sf. DR InterPro; IPR000436; Sushi_SCR_CCP_dom. DR PANTHER; PTHR45656:SF4; PROTEIN BETA CHAIN, PUTATIVE-RELATED; 1. DR PANTHER; PTHR45656; PROTEIN CBR-CLEC-78; 1. DR Pfam; PF00084; Sushi; 3. DR SMART; SM00032; CCP; 3. DR SUPFAM; SSF57535; Complement control module/SCR domain; 3. DR PROSITE; PS50923; SUSHI; 3. DR Genevisible; P20851; HS. PE 1: Evidence at protein level; KW Alternative splicing; Complement pathway; Disulfide bond; Glycoprotein; KW Immunity; Innate immunity; Reference proteome; Repeat; Secreted; Signal; KW Sushi. FT SIGNAL 1..17 FT CHAIN 18..252 FT /note="C4b-binding protein beta chain" FT /id="PRO_0000005892" FT DOMAIN 21..78 FT /note="Sushi 1" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00302" FT DOMAIN 79..136 FT /note="Sushi 2" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00302" FT DOMAIN 137..193 FT /note="Sushi 3" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00302" FT CARBOHYD 64 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000269|PubMed:14760718, FT ECO:0000269|PubMed:16335952" FT CARBOHYD 71 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000269|PubMed:14760718" FT CARBOHYD 98 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000269|PubMed:14760718, FT ECO:0000269|PubMed:16335952, ECO:0000269|PubMed:19159218" FT CARBOHYD 117 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 154 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT DISULFID 23..63 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00302" FT DISULFID 49..76 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00302" FT DISULFID 81..121 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00302" FT DISULFID 107..134 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00302" FT DISULFID 139..179 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00302" FT DISULFID 165..191 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00302" FT DISULFID 202 FT /note="Interchain (with alpha chain)" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00302" FT DISULFID 216 FT /note="Interchain (with alpha chain)" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00302" FT VAR_SEQ 20 FT /note="Missing (in isoform 2)" FT /evidence="ECO:0000303|PubMed:15489334" FT /id="VSP_022594" FT VARIANT 102 FT /note="K -> Q (in dbSNP:rs56258224)" FT /evidence="ECO:0000269|Ref.3" FT /id="VAR_038734" FT VARIANT 198 FT /note="P -> S (in dbSNP:rs1803226)" FT /id="VAR_012039" SQ SEQUENCE 252 AA; 28357 MW; 0F6CC64067C5E2E7 CRC64; MFFWCACCLM VAWRVSASDA EHCPELPPVD NSIFVAKEVE GQILGTYVCI KGYHLVGKKT LFCNASKEWD NTTTECRLGH CPDPVLVNGE FSSSGPVNVS DKITFMCNDH YILKGSNRSQ CLEDHTWAPP FPICKSRDCD PPGNPVHGYF EGNNFTLGST ISYYCEDRYY LVGVQEQQCV DGEWSSALPV CKLIQEAPKP ECEKALLAFQ ESKNLCEAME NFMQQLKESG MTMEELKYSL ELKKAELKAK LL //